SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Makers Laboratories - Quaterly Results

23 May 2024 Evaluate
The company witnessed a 5.64% growth in the revenue at Rs. 114.53 millions for the quarter ended March 2024 as compared to Rs. 108.42 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -15.57 millions as compared to Net Loss of Rs. -8.05 millions of corresponding quarter ended March 2023The company reported a good operating profit of 0.08 millions compared to 0.03 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 114.53 108.42 5.64 490.89 425.47 15.38 490.89 425.47 15.38
Other Income 1.48 1.79 -17.32 11.52 11.37 1.32 11.52 11.37 1.32
PBIDT 0.08 0.03 166.67 -26.09 -29.97 -12.95 -26.09 -29.97 -12.95
Interest 4.61 2.82 63.48 16.34 13.81 18.32 16.34 13.81 18.32
PBDT -4.53 -2.79 62.37 -42.43 -43.78 -3.08 -42.43 -43.78 -3.08
Depreciation 6.83 6.55 4.27 27.15 23.99 13.17 27.15 23.99 13.17
PBT -11.36 -9.34 21.63 -69.58 -67.77 2.67 -69.58 -67.77 2.67
TAX 4.21 -1.29 -426.36 -0.06 -4.15 -98.55 -0.06 -4.15 -98.55
Deferred Tax 4.23 -1.44 -393.75 -0.04 -4.30 -99.07 -0.04 -4.30 -99.07
PAT -15.57 -8.05 93.42 -69.52 -63.62 9.27 -69.52 -63.62 9.27
Equity 59.00 59.00 0.00 59.00 59.00 0.00 59.00 59.00 0.00
PBIDTM(%) 0.07 0.03 152.35 -5.31 -7.04 -24.55 -5.31 -7.04 -24.55

Makers Laboratories Share Price

155.80 -4.35 (-2.72%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×